Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11771652 Lipid nanoparticles for delivering mRNA vaccines

Patent 11771652 was granted and assigned to Sanofi on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Sanofi
Sanofi
Date Filed
November 5, 2021
Date of Patent
October 3, 2023
Patent Applicant
Sanofi
Sanofi
Patent Application Number
17520200
Patent Citations
‌
US Patent 9006417 Non-liposomal systems for nucleic acid delivery
‌
US Patent 9364435 Lipid formulations for nucleic acid delivery
‌
US Patent 9404127 Non-liposomal systems for nucleic acid delivery
‌
US Patent 7803397 Polyethyleneglycol-modified lipid compounds and uses thereof
‌
US Patent 8058069 Lipid formulations for nucleic acid delivery
‌
US Patent 8492359 Lipid formulations for nucleic acid delivery
‌
US Patent 8822668 Lipid formulations for nucleic acid delivery
‌
US Patent 8936942 Polyethyleneglycol-modified lipid compounds and uses thereof
‌
US Patent 10143758 Liver specific delivery of messenger RNA
‌
US Patent 10172935 Vaccination in newborns and infants
•••
Patent Inventor Names
Sudha Chivukula
Timothy Tibbitts
Frank Derosa
Rebecca L. Goldman
Shrirang Karve
Asad Khanmohammed
Anusha Dias
Priyal Patel
Danilo Casimiro
Timothy Plitnik
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11771652
Patent Primary Examiner
‌
Isaac Shomer

Find more entities like US Patent 11771652 Lipid nanoparticles for delivering mRNA vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo